| 摘要 |
<p>A pharmaceutical composition consisting of two locally separated preparations is provided which selectively suppresses tumor cell growth. Use of the composition consists of co-administering M-CSF and/or GM-CSF with specified isotypes of monoclonal antibodies.</p> |
